Document Detail

A study of the agreement between patient self-assessment and study personnel assessment of bleeding symptoms.
MedLine Citation:
PMID:  17076848     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Clinical trials investigating new platelet transfusion therapies frequently require the assessment of bleeding for the study outcome. These assessments are commonly performed by study personnel and can be time-consuming. The purpose of this study was to assess whether patients were able to reliably assess their bleeding status on a daily basis. STUDY DESIGN AND METHODS: Patients admitted to hospital to receive chemotherapy for acute leukemia or to undergo allogeneic peripheral blood progenitor cell transplant were included. Patients were given an introduction to a form for documenting the occurrence of 16 bleeding symptoms. Patients completed this form and were examined daily by a study assessor. A weekly health record review was also performed by a study assessor. The agreement between raters was determined by calculating the raw agreement, chance-corrected agreement, and chance-independent agreement. RESULTS: Thirty-five patients completed 458 assessment forms that were paired with 559 forms completed by a study assessor with 450 matched forms available for analysis (mean, 12.86 per patient). Agreement for most individual bleeding symptoms was high. Thirteen items had agreement greater than 90 percent and all items had agreement greater than 77 percent. The lowest agreement was seen for skin symptoms: petechiae (89.2%), purpura (80.9%), and ecchymosis (77.6%). The negative predictive value of patient self-assessment was high (range, 71.1%-100%) whereas the positive predictive value was lower (range, 0%-86.5%). CONCLUSION: The reliability was very good between patients and study assessors with the patients reporting excellent negative predictive value and variable positive predictive value.
Kathryn E Webert; Richard J Cook; Stephen Couban; Julie Carruthers; Nancy M Heddle
Related Documents :
10654888 - Clinical significance of gross hematuria and its evaluation in patients receiving antic...
1881848 - How to diagnose bleeding disorders.
24827068 - Relative importance of benefits and risks associated with antithrombotic therapies for ...
2003328 - Immunoadsorption for coagulation factor inhibitors.
15372258 - Chronic idiopathic axonal polyneuropathy revisited.
18566108 - Direct access to physical therapy in the netherlands: results from the first year in co...
Publication Detail:
Type:  In Vitro; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Transfusion     Volume:  46     ISSN:  0041-1132     ISO Abbreviation:  Transfusion     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-11-01     Completed Date:  2006-12-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1926-33     Citation Subset:  IM    
McMaster University, Hamilton, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hematologic Neoplasms / complications,  therapy
Hemorrhage* / etiology
Middle Aged
Peripheral Blood Stem Cell Transplantation / adverse effects
Personnel, Hospital*
Process Assessment (Health Care)*
Sensitivity and Specificity

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Population-based audit of fresh-frozen plasma transfusion practices.
Next Document:  Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confi...